Pebblebrook Sells Chamberlain West Hollywood for $43.5M at 14.5x EBITDA
Event summary
- Pebblebrook Hotel Trust sold the 115-room Chamberlain West Hollywood Hotel for $43.5 million on May 27, 2026.
- The sale price equated to a 14.5x EBITDA multiple and a 5.9% NOI capitalization rate.
- Proceeds will be used to reduce net debt, repurchase common shares, and support high-return capital allocation.
- Since 2021, Pebblebrook has sold over $1.0 billion of properties, demonstrating its ability to monetize assets at private-market values.
The big picture
Pebblebrook's sale of the Chamberlain West Hollywood Hotel is part of its disciplined capital allocation strategy, aimed at strengthening its balance sheet and enhancing long-term shareholder value. The transaction underscores the company's ability to monetize assets at attractive valuations, a trend that has seen it sell over $1.0 billion of properties since 2021. This strategic move aligns with broader industry trends of portfolio optimization and financial flexibility in the face of varying market conditions.
What we're watching
- Debt Reduction Strategy
- How Pebblebrook's focus on reducing net debt and preferred equity will impact its financial flexibility and long-term value per share.
- Capital Allocation
- Whether the company can sustain high-return capital allocation priorities while maintaining attractive private-market values for asset sales.
- Market Conditions
- The pace at which the U.S. hotel industry RevPAR growth rate and same-property metrics will influence Pebblebrook's revised 2026 outlook.